Basic research is very useful, but it should be more geared toward application than it was before.
We are working with a biotech company, Calypte, which has designed a urine test for the HIV antibody.
They don't actually see the real world, where 95% of the people with HIV are not treated and are dying. And even though we have some blue sky now in our country, the sky could become cloudy again very soon.
My proposal now is to test a vaccine first on people who have been infected, and if you show some efficacy at this level, you might be able to go further to study uninfected people in a population with a high rate of infection.
